RxDoctor Payments Data

Michael Shindle, MD

Sports Medicine · Wayne, NJNPI 1952578627

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Johnson & Johnson at 25.9% of the total. Reporting peaked in 2024 at $523 and has fallen 57.4% since, to $223 in 2025. That places this record below the midpoint for sports medicine clinicians in NJ, where the typical reported total is $1,237.

$1,387in general payments, 2019–2025

Across 39 payments — averaging $35.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$359
  • Ferring Pharmaceuticals Inc.$214
  • Miach Orthopaedics, Inc.$189
  • Smith+Nephew$157
  • Spinal Elements, Inc.$137
  • Zimmer Biomet$65
  • plus $264 from 7 others
$140,000in ownership & investment interests, 2019–2025

Across 7 payments — averaging $20,000 each. An ownership or investment interest held by the physician or an immediate family member.

  • Gramercy Extremity Orthopedics LLC$140K

What the payments were for

  • Food & beverage$1,387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,387 in reported general payments places this provider in the 50th percentile of 221 sports medicine providers in New Jersey.

See all sports medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$201,152
Medicare patients
339
Services billed
3,118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl11$795
Meloxicam288$702
Methylprednisolone66$413
Cyclobenzaprine Hcl55$366
Tramadol Hcl51$159

Paid to pharmacies, not to this prescriber.

Other sports medicine in Wayne

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →